France's most expensive drug costs €70,000 per patient

Pharmaceutical companies are defending the price of Zolgensma, a treatment for spinal muscular atrophy.

Published 3sem1 sourceImportant

≈ 19sSpeed

The fact

This drug represents the largest expense for France's national health insurance in 2024.

Its cost has sparked debate over funding for gene therapies in France.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on June 28, 2026